Low-dose Theophylline as Anti-inflammatory Enhancer in Severe Chronic Obstructive Pulmonary Disease

NCT01599871 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: theophylline
OTHER: placebo

Sponsor

Hospital Son Espases

Collaborators

[object Object]
[object Object]